TOP
|
特許
|
意匠
|
商標
商標ウォッチ
Twitter
他の商標を見る
公開日
2024-12-18
公報種別
公開国際商標公報
国際登録番号
1816403
国際登録日
2024-08-27
区分
第5類(薬剤)
,
第42類(科学・技術)
,
第44類(医療・農林業)
商品役務
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.
,
Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; medical testing and clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid.
,
Medical services; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information
,
consultancy and advisory services relating to the aforesaid.
基礎出願番号
UK00004024691
基礎出願日
2024-03-12
基礎出願国
GB
出願人
Bicycletx Limited
OCRテキスト
OCRテキスト2
B
OCRについて
この商標をJ-PlatPatで参照する
関連商標
Elevar Therapeutics, Inc.
1か月前
Entasis Therapeutics (Ireland) Limited
17日前
Soletluna Holdings, Inc.
10日前
FIN-CERAMICA FAENZA S.p.A
17日前
Survival IP Pty Ltd
17日前
Modere UK Limited
17日前
Novartis AG
17日前
Glaxo Group Limited
17日前
Glaxo Group Limited
17日前
Glaxo Group Limited
17日前
Glaxo Group Limited
17日前
Novartis AG
17日前
Novartis AG
17日前
Novartis AG
17日前
IGNAZIO LOI
17日前
FIN-CERAMICA FAENZA S.p.A.
17日前
Entasis Therapeutics (Ireland) Limited
17日前
Xi’an Tianlong Science and Technology Co., Ltd
10日前
Nant Holdings IP, LLC
17日前
Novartis AG
STOQUEPT
25日前
Novartis AG
STEZYLDA
25日前
TIM Holding B.V.
17日前
SIGNS
17日前
Nant Holdings IP, LLC
17日前
Nant Holdings IP, LLC
17日前
Celsius Live Fit International Designated Activity Company
17日前
Entasis Therapeutics (Ireland) Limited
17日前
Celsius Live Fit International Designated Activity Company
17日前
Novartis AG
17日前
NOVARTIS AG
17日前
Novartis AG
17日前
Novartis AG
17日前
Novartis AG
17日前
Shanghai HEP Biotechnology Co., Ltd
10日前
Neolife International, LLC
10日前
個人
HerbalGem es
25日前
続きを見る
他の商標を見る